|
US2008063638A1
|
|
Mitotic kinesin-like protein-1, MKLP1, and uses therof priority
|
|
WO2006100679A2
|
|
Recombinant antibodies against human type ii transglutaminase and uses thereof
|
|
WO2006035434A2
|
|
Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
|
|
BRPI0514395A
|
|
therapeutic use of rtp801 inhibitors
|
|
GEP20125516B
|
|
Therapeutic uses of inhibitors of rtp801
|
|
EP1753464A2
|
|
Annexin ii and uses thereof
|
|
WO2005056750A2
|
|
Inversion-duplication of nucleic acids and libraries prepared thereby
|
|
WO2004112566A2
|
|
Diagnosis and treatment of nephropathy
|
|
WO2004112565A2
|
|
Diagnosis and treatment of liver, pulmonary and cardiac fibrosis
|
|
WO2004110340A2
|
|
Ctla-2 and uses thereof
|
|
WO2004111182A2
|
|
Methods for cloning nucleic acids in a desired orientation
|
|
US2005004065A1
|
|
Hypoxia regulated genes
|
|
EP1624788A2
|
|
Use of endo180 receptor for diagnosis and treatment of disease
|
|
IL161199D0
|
|
sFRP1 AND USES THEREOF
|
|
AU2003286392A8
|
|
1microarrays and production thereof
|
|
IL158677D0
|
|
Uses of atrx
|
|
IL156922D0
|
|
Methods for identifying phenotype and protein activity inhibitors
|
|
IL156882D0
|
|
Isocitrate dehydrogenase and uses thereof
|
|
IL156883D0
|
|
Uses of wwp1 protein
|
|
IL156721D0
|
|
Str50 and uses thereof
|
